Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
admin Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of…
Read MoreAlzheimer's Disease
Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreA new type of service dog is helping people with dementia
An incident on his bike was the catalyst for John Wood getting a service dog.…
Read MoreOpinion: This is now the No. 1 preventable cause of Alzheimer’s in America
Here is yet more bleak news about the obesity epidemic: Obesity isn’t just killing millions…
Read More
When will we care as much about Alzheimer’s as we did about COVID-19?
Where is the hysteria? Where is the mass panic? Where is the preening virtue signaling?…
Read More